BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8292303)

  • 1. Apolipoprotein B mRNA editing: a key controlling element targeting fats to proper tissue.
    Davidson NO
    Ann Med; 1993 Dec; 25(6):539-43. PubMed ID: 8292303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein B RNA editing enzyme-deficient mice are viable despite alterations in lipoprotein metabolism.
    Morrison JR; Pászty C; Stevens ME; Hughes SD; Forte T; Scott J; Rubin EM
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7154-9. PubMed ID: 8692961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apobec-1 and apolipoprotein B mRNA editing.
    Chan L; Chang BH; Nakamuta M; Li WH; Smith LC
    Biochim Biophys Acta; 1997 Mar; 1345(1):11-26. PubMed ID: 9084497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of apo E deficiency on plasma lipid levels in mice lacking APOBEC-1.
    Osuga J; Yagyu H; Ohashi K; Harada K; Yazaki Y; Yamada N; Ishibashi S
    Biochem Biophys Res Commun; 1997 Jul; 236(2):375-8. PubMed ID: 9240444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein B messenger RNA editing: an update.
    Chan L
    Biochimie; 1995; 77(1-2):75-8. PubMed ID: 7599279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene transfer of cytidine deaminase apoBEC-1 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits.
    Hughes SD; Rouy D; Navaratnam N; Scott J; Rubin EM
    Hum Gene Ther; 1996 Jan; 7(1):39-49. PubMed ID: 8825867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superior role of apolipoprotein B48 over apolipoprotein B100 in chylomicron assembly and fat absorption: an investigation of apobec-1 knock-out and wild-type mice.
    Kendrick JS; Chan L; Higgins JA
    Biochem J; 2001 Jun; 356(Pt 3):821-7. PubMed ID: 11389690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations and variants of apolipoprotein B that affect plasma cholesterol levels.
    Innerarity TL; Boström K
    Adv Exp Med Biol; 1991; 285():25-31. PubMed ID: 1858554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct promoters induce APOBEC-1 expression in rat liver and intestine.
    Greeve J; Axelos D; Welker S; Schipper M; Greten H
    Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1079-92. PubMed ID: 9672068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cloning of an apolipoprotein B messenger RNA editing protein.
    Teng B; Burant CF; Davidson NO
    Science; 1993 Jun; 260(5115):1816-9. PubMed ID: 8511591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning of a human small intestinal apolipoprotein B mRNA editing protein.
    Hadjiagapiou C; Giannoni F; Funahashi T; Skarosi SF; Davidson NO
    Nucleic Acids Res; 1994 May; 22(10):1874-9. PubMed ID: 8208612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-mediated gene transfer of rat apolipoprotein B mRNA-editing protein in mice virtually eliminates apolipoprotein B-100 and normal low density lipoprotein production.
    Teng B; Blumenthal S; Forte T; Navaratnam N; Scott J; Gotto AM; Chan L
    J Biol Chem; 1994 Nov; 269(47):29395-404. PubMed ID: 7961918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA editing: a novel mechanism for regulating lipid transport from the intestine.
    Scott J; Wallis SC; Davies MS; Wynne JK; Powell LM; Driscoll DM
    Gut; 1989 Nov; 30 Spec No(Spec No):35-43. PubMed ID: 2606364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein B mRNA editing is preserved in the intestine and liver of zinc-deficient rats.
    Nassir F; Blanchard RK; Mazur A; Cousins RJ; Davidson NO
    J Nutr; 1996 Apr; 126(4):860-4. PubMed ID: 8613888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased hepatic synthesis and accumulation of plasma apolipoprotein B100 in copper-deficient rats does not result from modification in apolipoprotein B mRNA editing.
    Nassir F; Giannoni F; Mazur A; Rayssiguier Y; Davidson NO
    Lipids; 1996 Apr; 31(4):433-6. PubMed ID: 8743057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein B mRNA editing protein: a tool for dissecting lipoprotein metabolism and a potential therapeutic gene for hypercholesterolemia.
    Chan L; Teng BB; Lau P
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():31-2. PubMed ID: 8767453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOLIPOPROTEIN B: mRNA editing, lipoprotein assembly, and presecretory degradation.
    Davidson NO; Shelness GS
    Annu Rev Nutr; 2000; 20():169-93. PubMed ID: 10940331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48.
    Hirano K; Young SG; Farese RV; Ng J; Sande E; Warburton C; Powell-Braxton LM; Davidson NO
    J Biol Chem; 1996 Apr; 271(17):9887-90. PubMed ID: 8626621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100.
    Farese RV; Véniant MM; Cham CM; Flynn LM; Pierotti V; Loring JF; Traber M; Ruland S; Stokowski RS; Huszar D; Young SG
    Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6393-8. PubMed ID: 8692825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine.
    Powell LM; Wallis SC; Pease RJ; Edwards YH; Knott TJ; Scott J
    Cell; 1987 Sep; 50(6):831-40. PubMed ID: 3621347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.